Enlightenment Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.28M |
| 2 |
Bath & Body Works
BBWI
|
+$2.16M |
| 3 |
Alibaba
BABA
|
+$2.08M |
| 4 |
Micron Technology
MU
|
+$1.88M |
| 5 |
Oracle
ORCL
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.57M |
| 2 |
Accenture
ACN
|
+$1.97M |
| 3 |
XYZ
Block Inc
XYZ
|
+$1.92M |
| 4 |
Morgan Stanley
MS
|
+$1.78M |
| 5 |
Adobe
ADBE
|
+$1.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 21.55% |
| 3 | Communication Services | 11.88% |
| 4 | Financials | 11.17% |
| 5 | Healthcare | 7.6% |
Similar funds
Enlightenment Research's Q4 2021 Portfolio in Review
As of Q4 2021, Enlightenment Research held 210 positions worth $70.3M, down 14% from $81.9M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Enlightenment Research withdrew a net $9.08M in Q4 2021, closing 89 positions and reducing 27 holdings. Its most notable exit was Palantir, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Enlightenment Research opened a new position in Microsoft worth $4.44M.
- Enlightenment Research's largest Q4 2021 buy was Microsoft: 13,200 shares worth $4.44M.
- Enlightenment Research added most to Bath & Body Works in Q4 2021, an estimated $2.16M increase.
- Enlightenment Research's biggest Q4 2021 reduction was Accenture, cutting an estimated $1.97M.
- Enlightenment Research fully exited Palantir in Q4 2021, selling an estimated $2.57M.
- Enlightenment Research's ten largest holdings make up 32% of its $70.3M portfolio in Q4 2021.
- Enlightenment Research opened 81 new positions and closed 89 in Q4 2021.
- Enlightenment Research's portfolio value fell 14% quarter-over-quarter to $70.3M.
Based on Enlightenment Research's 13F filing for Q4 2021, filed 14 Feb 2022.